Pharma Equity Group A/S Cl A (PEG) — Cash Flow-to-Debt Ratio
Pharma Equity Group A/S Cl A (PEG) has a Cash Flow-to-Debt Ratio of -0.40x as of December 2024, meaning its operating cash flow of Dkr-6.66 Million could theoretically repay 0% of its total liabilities (Dkr16.73 Million) in one year. See PEG free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Pharma Equity Group A/S Cl A Cash Flow-to-Debt Ratio (2009–2025)
Historical debt coverage capacity for Pharma Equity Group A/S Cl A across 17 annual periods. Also explore net asset growth rate of Pharma Equity Group A/S Cl A to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Pharma Equity Group A/S Cl A (2009–2025)
Year-by-year debt coverage analysis for Pharma Equity Group A/S Cl A. For market capitalisation and broader financial context, see Pharma Equity Group A/S Cl A stock valuation.
| Year | CF-to-Debt Ratio | Operating CF (DKK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.32x | Dkr-17.66 Million | Dkr13.43 Million | ▲ +3.7% |
| 2024 | -1.37x | Dkr-22.86 Million | Dkr16.73 Million | ▼ -248.5% |
| 2023 | -0.39x | Dkr-16.62 Million | Dkr42.40 Million | ▼ -241.4% |
| 2022 | -0.11x | Dkr-2.87 Million | Dkr25.03 Million | ▼ -15.9% |
| 2021 | -0.10x | Dkr-2.09 Million | Dkr21.08 Million | ▲ +76.7% |
| 2020 | -0.43x | Dkr-9.90 Million | Dkr23.30 Million | ▼ -2022.7% |
| 2019 | -0.02x | Dkr-274.00K | Dkr13.68 Million | ▲ +95.9% |
| 2018 | -0.48x | Dkr-1.58 Million | Dkr3.27 Million | ▲ +88.1% |
| 2017 | -4.07x | Dkr-4.92 Million | Dkr1.21 Million | ▼ -65060.9% |
| 2016 | -0.01x | Dkr-181.00K | Dkr28.98 Million | ▲ +94.3% |
| 2015 | -0.11x | Dkr-2.94 Million | Dkr26.72 Million | ▲ +40.4% |
| 2014 | -0.18x | Dkr-4.80 Million | Dkr26.02 Million | ▼ -1036.6% |
| 2013 | -0.02x | Dkr-5.79 Million | Dkr356.68 Million | ▲ +28.1% |
| 2012 | -0.02x | Dkr-10.56 Million | Dkr467.46 Million | ▼ -69.3% |
| 2011 | -0.01x | Dkr-5.71 Million | Dkr428.10 Million | ▲ +66.6% |
| 2010 | -0.04x | Dkr-17.75 Million | Dkr444.20 Million | ▼ -19.4% |
| 2009 | -0.03x | Dkr-744.00K | Dkr22.24 Million | — |